Autism Spectrum Disorder Trial, Recruiting NCT07222982 Sponsor: Drexel University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07222982
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have graduated from high school (or an equivalent program) and are between 18 and 30 years old
  • You are able to read, understand, and complete all study materials and activities in English
  • You score at or above a certain level on the RAADS, which is a screening questionnaire related to autism traits (confirm with trial site for exact score requirement)
  • You score at or above a certain level on the KBIT-2R, which is a test that measures thinking and reasoning skills (confirm with trial site for exact score requirement)
  • You score at or above a certain level on the ADOS-2, which is a standardized assessment used to evaluate autism-related characteristics (confirm with trial site for exact score requirement)
  • You are physically able to take part in all study activities without any significant physical or mental health condition getting in the way
  • You are able to travel in person to the AJ Drexel Autism Institute at Drexel University in Philadelphia, PA, for weekly sessions

Who may not be able to join:

  • You are currently still enrolled in high school (or an equivalent program), or you are outside the 18–30 age range
  • You are not able to complete the study materials or activities in English
  • You are not able to go through the consent process
  • You score below the required levels on the RAADS, KBIT-2R, or ADOS-2 assessments (confirm with trial site for exact score thresholds)
  • You are not physically able to take part in the study activities
  • You are not able to travel to the study site in Philadelphia, PA for the weekly sessions
  • You have a serious medical or mental health condition that would make it unsafe for you to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matthew Lerner, PhD, Drexel University

Phone: 5105085858

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Drexel University
Registry
ClinicalTrials.gov
Start date
15 January 2026
Est. completion
1 February 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Social Responsiveness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov